Ribose (Furanose)

Ribose (Furanose)

SCHEMBL17479515

Cc1cnccc1C(N)=O.OC[C@H]1OC(O)[C@H](O)[C@@H]1O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.47
▸ SIRT3 Q9NTG7 1/20 0.47
▸ MKNK1 Q9BUB5 1/20 0.39
▸ MKNK2 Q9HBH9 1/20 0.39
▸ LMNA P02545 3/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ EIF4E P06730 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ TOP1 P11387 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ THPO P40225 1/20 0.38
▸ PMP22 Q01453 1/20 0.38
▸ KDM4E B2RXH2 2/20 0.38
▸ GAA P10253 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ribose (Furanose) SCHEMBL5827542 0.81 TDP1 (0.44) TDP1SIRT3ALDH1A1KDM4EMAPT
SCHEMBL36668757 0.78 TDP1 (0.71) TDP1SIRT3MKNK1MKNK2ALDH1A1
SCHEMBL286483 0.78 TDP1 (0.71) TDP1SIRT3MKNK1MKNK2ALDH1A1
SCHEMBL27606205 0.78 UMPS (0.44) TDP1SIRT3LMNASMN1; SMN2ALDH1A1
SCHEMBL27588394 0.78 UMPS (0.44) TDP1SIRT3LMNASMN1; SMN2ALDH1A1
SCHEMBL6784339 0.78 UMPS (0.44) TDP1SIRT3LMNASMN1; SMN2ALDH1A1
SCHEMBL6790961 0.78 UMPS (0.44) TDP1SIRT3LMNASMN1; SMN2ALDH1A1
Ribose (Furanose) SCHEMBL15881395 0.76 TDP1 (0.35) TDP1SIRT3LMNASMN1; SMN2ALDH1A1
Ribose (Furanose) SCHEMBL18185139 0.76 F7 (0.59) SIRT3MKNK1MKNK2LMNASMN1; SMN2
Ribose (Furanose) SCHEMBL14321532 0.76 F7 (0.59) SIRT3MKNK1MKNK2LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174551-A1 AGENTS FOR USE IN TREATING LIVER AND PANCREATIC CANCER Fundación Centro Nacional de Investigaciones Oncológicas Carlos III (ES) 2017-06-07 — — EP claimed
WO-2016016391-A1 AGENTS FOR USE IN TREATING LIVER AND PANCREATIC CANCER FUNDACIÓN CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS CARLOS III (ES) 2016-02-04 — — WO claimed
Send feedback